Literature DB >> 2830586

Viral infections in pediatric bone marrow transplant patients.

R Wasserman1, C S August, S A Plotkin.   

Abstract

The records of 96 pediatric patients with aplastic anemia or a malignancy who underwent bone marrow transplantation between 1979 and 1986 at The Children's Hospital of Philadelphia were reviewed for laboratory evidence of viral infections. The most common viral diseases identified were herpes simplex virus (HSV), cytomegalovirus and adenoviruses, which were found in 19 (20%), 17 (18) and 17 (18) patients, respectively. HSV was more common in patients with than without graft vs. host disease (GVHD) (9 of 30; 30% vs. 10 of 66; 15%), but the difference did not reach statistical significance. Late or prolonged isolation of HSV occurred in patients with chronic GVHD. Cytomegalovirus was significantly more common in patients with than without GVHD (10 of 30; 33% vs. 7 of 66; 11%). The presence of pretransplant antibody to cytomegalovirus or HSV was a good predictor of subsequent infection. Adenoviruses were isolated from all 3 patients with Burkitt's lymphoma. Adenovirus type 12, a serotype uncommon in man and known to be highly tumorigenic in young hamsters, was recovered from 4 patients. Adenoviruses were not notably more common in patients with GVHD (6 of 30; 20% vs. 11 of 66; 17%). Other viral infections demonstrated included 5 parainfluenza, 4 enteroviruses, 3 human immunodeficiency virus, 1 respiratory syncytial virus, 1 influenza B and 1 rhinovirus.

Entities:  

Mesh:

Year:  1988        PMID: 2830586     DOI: 10.1097/00006454-198802000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  18 in total

1.  Adenovirus infection in pediatric liver transplant recipients.

Authors:  M G Michaels; M Green; E R Wald; T E Starzl
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

2.  Adenovirus: current epidemiology and emerging approaches to prevention and treatment.

Authors:  Uriel Sandkovsky; Luciano Vargas; Diana F Florescu
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

Review 3.  Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment.

Authors:  H K Holland; R Saral
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

4.  Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.

Authors:  Diana F Florescu; Steven A Pergam; Michael N Neely; Fang Qiu; Christine Johnston; SingSing Way; Jane Sande; Deborah A Lewinsohn; Judith A Guzman-Cottrill; Michael L Graham; Genovefa Papanicolaou; Joanne Kurtzberg; Joseph Rigdon; Wendy Painter; Herve Mommeja-Marin; Randall Lanier; Maggie Anderson; Charles van der Horst
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

5.  PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease.

Authors:  M S Echavarria; S C Ray; R Ambinder; J S Dumler; P Charache
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression.

Authors:  J M Routes; B A Metz; J L Cook
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 7.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 8.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

Review 9.  Correlation of pretransplant viral serology and complications of bone marrow transplantation.

Authors:  O Ringdén
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 10.  The challenge of respiratory virus infections in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh
Journal:  Br J Haematol       Date:  2008-09-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.